Nūhou

I ka hapa mua o 2022, ua hoʻokuʻu ʻia nā huahana olakino e like me ka lāʻau lapaʻau Korea, nā mea lapaʻau a me nā mea hoʻonaninani i hōʻea i kahi moʻolelo kiʻekiʻe.Hoʻonui ka hoʻokuʻu ʻana aku i nā mea hoʻopuka diagnostic COVID-19 a me nā kano.
Wahi a ka Korea Health Industry Development Institute (KHIDI), he $13.35 biliona ka nui o ka lawe ʻana o ka ʻoihana i ka hapa mua o kēia makahiki.Ua piʻi kēlā helu he 8.5% mai $ 12.3 biliona i ka hapaha makahiki i hala a ʻo ia ka hopena kiʻekiʻe loa o ka hapalua makahiki.Ua hoʻopaʻa ʻia ma luna o $ 13.15 biliona i ka hapa lua o 2021.
Ma ka ʻoihana, ʻo ka hoʻokuʻu ʻana i nā lāʻau lapaʻau he US $ 4.35 biliona, ʻoi aku ka 45.0% mai ka US $ 3.0 biliona i ka manawa like ma 2021. ʻO ka lawe ʻana aku i nā lāʻau lapaʻau he $ 4.93 biliona, ʻoi aku ka 5.2% i kēlā me kēia makahiki.Ma muli o ka quarantine ma Kina, ua hāʻule nā ​​​​mea hoʻonaninani e 11.9% i $ 4.06 biliona.
Ua alakaʻi ʻia ka ulu ʻana o nā lāʻau lapaʻau e nā biopharmaceuticals a me nā lāʻau lapaʻau.ʻO ka lawe ʻana aku o nā biopharmaceuticals i $ 1.68 biliona, aʻo ka lawe ʻana aku i nā kano he $780 miliona.Loaʻa nā mea ʻelua no 56.4% o nā lāʻau lapaʻau āpau.ʻO ka mea kūikawā, ua hoʻonui ʻia ka hoʻokuʻu ʻana o nā kano i ka 490.8% i kēlā me kēia makahiki ma muli o ka hoʻonui ʻia ʻana o ka hoʻokuʻu ʻia ʻana o nā kano kūʻē iā COVID-19 i hana ʻia ma lalo o ka hana ʻaelike.
Ma ke kahua o nā lāʻau lapaʻau, hōʻike nā diagnostic reagents i ka hapa nui loa, a hiki i $ 2.48 biliona, ma luna o 2.8% mai ka manawa like ma 2021. Eia kekahi, nā hoʻouna ʻana i nā mea hana kiʻi ultrasound ($ 390 miliona), implants ($ 340 miliona) a me X- Ua hoʻomau ka ulu ʻana o nā lako ray ($330 miliona), ma ka US a me Kina.